The rest of this story is for members
The rest is for members
The story continues: the full timeline, the transaction ranges, and the names the forms carry.
Premium comes through the Telegram channel. Already have a code? Sign in to activate it.
A new director at biotech company REGENXBIO purchased a million dollars worth of shares two days after his appointment, as the company approaches significant clinical and regulatory milestones.
The rest of this story is for members
The story continues: the full timeline, the transaction ranges, and the names the forms carry.
Premium comes through the Telegram channel. Already have a code? Sign in to activate it.
Good intel travels.
Share this story
Insiders·RAPP·3h ago·3 min read
InsidersRAPP
3h ago · 3 min
Insiders·SGRY·1d ago·3 min read
InsidersSGRY
1d ago · 3 min
PremiumInsiders·NOK·1d ago·3 min read
InsidersPremiumNOK
1d ago · 3 min